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expression of collagen type X, whereas Wnt5a, Wnt5b that de-
lay hypertrophy of cartilage were down-regulated coinciding with
down-regulation of Sox9, Collagen II, and Aggrecan. Finally, in-
creased levels of β-catenin have been observed in degenerative
cartilage.
Conclusions: Our data suggest that Wnt/beta-catenin signaling
involved in endochondral ossiﬁcation may be important for the
onset and progression of OA. Also these molecular changes
involved in endochondral ossiﬁcation coincided with molecular
changes of IL1β, IFNγ and TNFα, known to be part of mechanisms
leading to excessive remodeling and degradation of cartilage
matrix in OA.
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AUTOPHAGY IS A PROTECTIVE MECHANISM IN NORMAL
CARTILAGE AND ITS AGING-RELATED LOSS IS LINKED
WITH CELL DEATH AND OSTEOARTHRITIS
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Purpose: Autophagy is a process for turnover of intracellular
organelles and molecules that protects cells during stress re-
sponses. This study evaluated the potential role of ULK1, an
inducer of autophagy, Beclin1, a regulator of autophagy and LC3,
which executes autophagy, in the development of osteoarthritis
(OA) and in cartilage cell death.
Methods: DNA array studies were performed to analyze differ-
ences in the expression of ULK1 in normal and OA human knee
cartilage. Protein expression of ULK1, Beclin1 and LC3 was an-
alyzed in human normal and OA chondrocytes and cartilage by
western blot and immunohistochemistry (IHC). Autophagy mark-
ers were also studied in mouse models of aging-associated and
surgically-induced OA. The apoptosis marker poly-ADP(ribose)
polymerase (Parp p85) was used to determine the relationship
between cell death and autophagy.
Results: In normal human articular cartilage ULK1, Beclin1 and
LC3 were constitutively expressed. ULK1 gene expression and
ULK1, Beclin1 and LC3 protein expression were reduced in OA
chondrocytes and cartilage but these three proteins were ex-
pressed in the cell clusters in OA cartilage. In mouse knee
joints loss of glycosaminoglycans (GAGs) was observed at 9
months of age and in the surgical OA model 8 weeks after knee
destabilization. Expression of ULK1, Beclin1 and LC3 decreased
together with loss of GAGs, suggesting decreased autophagy cor-
relates with extracellular matrix changes in OA. The decrease
in autophagy in the same human and mouse OA cartilage was
associated with an increase in Parp p85.
Conclusions: Autophagy may be a protective or homeostatic
mechanism in normal cartilage. By contrast, human OA, sponta-
neous and surgically-induced OA in mice are associated with a
reduction and loss of ULK1, Beclin1 and LC3 expression and a
related increase in apoptosis. These results suggest that compro-
mised autophagy represents a novel mechanism in the develop-
ment of OA.
189
HYPEROSMOTIC STIMULATION OF CHONDROCYTES
LEADS TO DIFFERENTIAL POST-TRANSCRIPTIONAL
REGULATION OF SOX9 AND COL2A1 mRNA
S.R. Tew, P.D. Clegg
Univ. of Liverpool, Liverpool, United Kingdom
Purpose: Post transcriptional control of SOX9 mRNA has been
shown to occur following exposure of human articular chondro-
cytes (HAC) to stress conditions (cycloheximide, hyperosmolarity).
These conditions lead to stabilisation of the mRNA and an in-
crease in its steady state levels. In this study we have started to
examine how sequences within the SOX9 3‘UTR may control this
process and how the chondrocyte speciﬁc collagen gene COL2A1
responds under similar conditions.
Methods: Freshly isolated HAC were plated as high density mono-
layer cultures and used within 48 hours. Cells were cultured for
5 hours under 380mOsm (control) or 550mOsm (hyperosmotic)
conditions before RNA was isolated. To measure t1/2 of mRNA,
actinomycin D chase experiments were performed under these
conditions. SOX9 and COL2A1 mRNA levels were determined
by qPCR. SOX9 3’UTR was ampliﬁed by RT-PCR and cloned
into pGEMT-Easy before being subcloned into the pBBB reporter
vector and transfected into NIH/3T3 cells.
Results: Hyperosmotic stimulation of HAC led to increased SOX9
mRNA levels which was associated with an increase in the mRNA
t1/2. Conversely, COL2A1 mRNA levels were slightly decreased
and this change was associated with a decrease in the mRNA
t1/2. Introduction of the SOX9 3‘ UTR sequence into the pBBB
reporter vector destabilised the encoded β-globin transcript (pBBB
= 17.7 hours, pBBB_S9UTR = 2.8 hours).
Conclusions: Despite increased SOX9 levels, COL2A1 mRNA
levels decrease in HAC exposed to hyperosmotic conditions.
Changes in both genes appear to involve a post transcriptional
mechanism but display opposite responses. Elements within the
SOX9 3‘UTR act to destabilise transcripts and are likely to interact
with the RNA regulatory proteins. Understanding this post tran-
scriptional control mechanism could help us to regulate cartilage
gene expression during tissue regeneration and disease.
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ENDOTHELIAL NITRIC OXIDE SYNTHASE DEFICIENCY
RESULTS IN REDUCED CHONDROCYTE PROLIFERATION
AND ENDOCHONDRAL BONE GROWTH
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Purpose: Nitric oxide (NO) has been implicated in the local reg-
ulation of bone metabolism. However, the contribution made by
speciﬁc nitric oxide synthase (Nos) enzymes to bone develop-
ment is unclear. Here we describe the effects of inactivation of
endothelial nitric oxide synthase (eNos) on cartilage development
and early endochondral bone formation in mice.
Methods: We used eNos-deﬁcient mice to address the role of
this gene in cartilage development in vivo. Methods used in
this projects include bone growth, histological staining, immuno-
histochemistry, BrdU incorporation assay, real-time RT-PCR and
western-blotting.
Results: Mice carrying this mutation show increased lethality and
marked abnormalities in bone formation. Tibiae and femurs from
newborn mutant mice were signiﬁcantly shorter. Histological sec-
tions demonstrated thinner cortical bone and fewer trabeculae in
mutant mice, delayed primary and secondary ossiﬁcation and a
larger area of collagen X expression (a marker of late chondrocyte
differentiation). eNos-deﬁcient growth plates are disorganized and
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hypocellular, with decreased chondrocyte number. BrdU incorpora-
tion assays and immunohistochemical staining for proliferating cell
nuclear antigen (PCNA) showed a marked reduction in replicating
cells in mutant mice. In addition, proliferation assays revealed de-
creased chondrocyte numbers from mutant mice in culture, which
is rescued by NO donor treatments (DATA-NO and SNAP). Organ
culture of tibiae from E15.5 eNos mutant mice demonstrates re-
duced bone growth and chondrocyte proliferation compared with
the wild type littermates, suggesting that the role of eNOS sig-
naling in chondrocyte proliferation is cell-autonomous. Reduced
chondrocyte number may in part be due to premature cell-cycle
exit because of decreased cyclin D1 and increased p57 expression
in mutants. Additional, reactive oxygen species were increased in
mutant chondrocytes as indicated by a ﬂuorescent dye (DCFH), in
parallel to increased apoptosis as indicated by increased staining
for cleaved caspase-3. Mutant mice also demonstrated increased
total and phosphorylated p38 and GSK-3β, reduced total and
phosphorylated Akt, and decreased SOX9 expression.
Conclusions: In summary, these data identify an essential role
of eNOS in chondrocyte proliferation, endochondral bone growth
and demonstrate that the eNOS gene regulates the coordination
between cell-cycle exit and chondrocyte differentiation in cartilage.
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CHONDROCYTES
M. Otero1, D.A. Plumb1, C. Dragomir1, K. Tsuchimochi1,
J. Chen1, D. Gluck1, P. Roman1, J. Harkess1, L. Xu2, Y. Li2,
M.B. Goldring1
1Hosp. for Special Surgery, New York, NY; 2Harvard Sch. of
Dental Med., Boston, MA
Purpose: Matrix metalloproteinase (MMP)-13 plays a major role in
osteoarthritis (OA) due to its-rate limiting role in collagen degrada-
tion. MMP-13 expression is regulated by a variety of transcription
factors including ESE-1, a member of the E26 transformation-
speciﬁc sequence (ETS) family. ESE-1 is induced by inﬂammatory
cytokines and is expressed in OA chondrocytes, where it represses
type II collagen promoter activity. The aim of this study was to
determine whether ESE-1 participates in MMP-13 transcriptional
regulation in chondrocytes.
Methods: The binding of in vitro-translated ESE-1 to the MMP-
13 promoter was analyzed by electrophoretic mobility shift as-
say (EMSA) and supershift analysis. To analyze the response of
the MMP-13 promoter to ESE-1, luciferase reporter assays were
performed using cell extracts of C-28/I2 and T/C-28a2 cells co-
transfected with constructs of the human MMP-13 promoter and
expression vectors encoding ESE-1, Runx2, cFos and cJun. For
knockdown of ESE-1 expression, human primary chondrocytes
and human immortalized chondrocytes were transfected with a
pool of four individual siRNA oligonucleotides against ESE-1 or
control nonspeciﬁc siRNA. After incubation for 96 h, the knock-
down was conﬁrmed by real time PCR and Western blotting,
and MMP-13 mRNA was analyzed by real time PCR. ESE-1 and
MMP-13 protein levels and type II collagen cleavage products
were addressed by immunohistochemical staining in human OA
cartilage, cho/+ mouse cartilage and Ese1 -/- mouse cartilage
specimens.
Results: Immunohistochemical analysis revealed increased ESE-
1 levels in both human and mouse OA cartilage specimens, and
ESE-1 co-localization with MMP-13 protein and type II collagen
cleavage products. EMSA and supershift analysis detected speciﬁc
binding of ESE-1 to three ETS sites in the proximal MMP-13
promoter. Luciferase reporter assays showed that ESE-1 over-
expression leads to the MMP-13 promoter activation in synergism
with Runx2 and AP-1 (cFos/cJun). Deletion of the sequences
containing the ESE-1 binding sites blocked activity. Real time
PCR analysis revealed lower MMP-13 basal mRNA expression
associated with ESE-1 knockdown and signiﬁcant reduction of IL-
1-induced MMP-13 mRNA levels. Immunohistochemical analysis
of cartilage from Ese1 -/- mice revealed low or undetectable
MMP-13 protein levels compared to wild type mice.
Conclusions: Our results in chondrocyte cultures suggest that
this transcription factor participates in the cytokine-induced activa-
tion of MMP-13 gene expression, as well as in the maintenance of
basal expression. Moreover, our ﬁnding that increased ESE-1 lev-
els in OA cartilage correlate with increased MMP-13 protein and
type II collagen cleavage products highlights its involvement in car-
tilage catabolic processes. Indeed, we are currently investigating
the relative contribution of ESE-1 absence to the OA onset and
progression in mouse OA models. Finally, the decreased MMP-13
protein levels in the cartilage of Ese1 -/- mice further reinforces the
role of the ESE-1 in homeostatic cartilage remodeling. Altogether,
our results show that ESE-1 is a key regulator of MMP-13 gene
expression in chondrocytes.
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CELL DEATH IN CHONDROCYTES DURING THE
PATHOGENESIS OF OSTEOARTHRITIS IS A COMBINATION
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Purpose: The aim of this study was to identify the type of death
that chondrocytes undergo and to correlate it with changes in
the endoplasmic reticulum (ER) and Golgi complex in the three
zones of the cartilage during Osteoarthritis (OA) pathogenesis in
an experimental model.
Methods: The experimentally OA-induced model was accom-
plished by unilateral knee menisectomy and post-surgery training;
normal rats were used as a control. Animals were sacriﬁced by
CO2 overdose and right femoral condyles were removed and
processed for either electron microscopy (EM) or Immunohisto-
chemistry (IHC). Chondrocytes death was identiﬁed with TUNEL
and IHC for cleaved caspase 3 active and LC3II in cartilage from
rats with 5, 10, 20 and 45 training days (td). At the same time
development of ER and G membranes were monitored with mark-
ers to calnexin and 58k-9 protein respectively. EM was used as a
complementary methodology to identify ER, Golgi complex (at 5
td) and autophagic vacuoles (20 td) in OA cartilage.
Results: Cell death analysis showed that throughout early stages
of OA, chondrocytes death started by apoptosis in the superﬁcial
(SZ) and middle zones (MZ) of the cartilage. As the degenerative
process progressed, autophagy began to be evident in the SZ.
Finally, in late stages of OA, chondrocytes co-expressed both
death markers in the SZ and MZ; while in the deep zone (DZ), just
apoptosis was discernible. In agreement with cell death processes,
ER and Golgi complex suffered changes during the ﬁrst 5 td and
showed a prominent ER with dilated cisterns and enhanced Golgi
complex membranes; in late stages of OA these changes were
maintained especially in the SZ and MZ.
Conclusions: Our results suggest that during the OA pathogene-
sis, chondrocytes undergo changes to increase their synthetic as
well as catabolic activities at early stages and late stages of OA
respectively. Afterward, at late stages of OA, when chondrocytes
repair capacity is overwhelm, they activate its own program of
cellular death, which includes autophagy, apoptosis and changes
in ER and G, characteristics of chondroptosis.
